Show simple item record

dc.contributor.authorCarserides, Constandinos
dc.contributor.authorSmith, Kieron
dc.contributor.authorZinicola, Marta
dc.contributor.authorKumar, Abhinav
dc.contributor.authorSwedrowska, Magda
dc.contributor.authorScala, Carlo
dc.contributor.authorCameron, Gary
dc.contributor.authorRiches, Zoe
dc.contributor.authorIannelli, Francesco
dc.contributor.authorPozzi, Gianni
dc.contributor.authorHold, Georgina
dc.contributor.authorForbes, Ben
dc.contributor.authorKelly, Charles G
dc.contributor.authorHijazi, Karolin
dc.date.accessioned2022-09-14T13:45:01Z
dc.date.available2022-09-14T13:45:01Z
dc.date.issued2022-09-13
dc.identifier.citationCarserides , C , Smith , K , Zinicola , M , Kumar , A , Swedrowska , M , Scala , C , Cameron , G , Riches , Z , Iannelli , F , Pozzi , G , Hold , G , Forbes , B , Kelly , C G & Hijazi , K 2022 , ' Comprehensive study of antiretroviral drug permeability at the cervicovaginal mucosa via an in vitro model ' , Pharmaceutics , vol. 14 , no. 9 , 1938 . https://doi.org/10.3390/pharmaceutics14091938en
dc.identifier.issn1999-4923
dc.identifier.otherPURE: 219289896
dc.identifier.otherPURE UUID: 5dec56d4-8cfd-49e3-8bad-1a977a73c953
dc.identifier.otherPubMed: 36145684
dc.identifier.otherScopus: 85138632184
dc.identifier.urihttps://hdl.handle.net/2164/19173
dc.descriptionFunding: This work was supported by the European Union’s Seventh Programme for research, technological development and demonstration under grant agreement No 305316 as part of the MOTIF (Microbicides Formulation Through Innovative Formulation for Vaginal and Rectal Delivery) project. Acknowledgments: We thank all members of the MOTIF consortium for helpful discussions and exchange of ideas during the course of this study.en
dc.format.extent22
dc.language.isoeng
dc.relation.ispartofPharmaceuticsen
dc.rights© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).en
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectHIV‐1en
dc.subjectfemale genital tracten
dc.subjectdarunaviren
dc.subjecttenofoviren
dc.subjectdapivirineen
dc.subjectdrug permeabilityen
dc.subjectdrug transportersen
dc.subjectdual chamber modelen
dc.subjectHEC-1Aen
dc.subjectR Medicineen
dc.subject.lccRen
dc.titleComprehensive study of antiretroviral drug permeability at the cervicovaginal mucosa via an in vitro modelen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Rowett Instituteen
dc.contributor.institutionUniversity of Aberdeen.Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Dental Educationen
dc.contributor.institutionUniversity of Aberdeen.Institute of Medical Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.3390/pharmaceutics14091938


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record